New, Optically Active, Phosphine Oxazoline Ligands
J . Org. Chem., Vol. 66, No. 1, 2001 213
300 MHz) δ 7.81 (s, 2H), 7.40 (m, 4H), 7.30 (m, 6H), 4.40 (m,
2H), 4.00 (m, 1H), 3.67 (s, 3H), 2.25 (m, 1H), 2.10 (m, 1H),
1.83 (m, 1H), 1.67 (m, 1H), 1.42 (s, 18H); 13C NMR (CDCl3, 75
MHz) δ 164.0, 162.5, 143.9, 138.4, 132.9, 132.6, 128.7-128.4,
126.8, 122.0, 72.0, 67.5 (d, J ) 14 Hz), 64.4, 35.8, 32.1(d, J )
16.5 Hz), 31.9, 24.0 (d, J ) 12.0 Hz); 31P NMR (CDCl3, 121
MHz) δ -15.20; HRMS (M+ + 1) m/z calcd for C32H41NOP
502.28749, found 502.28731.
(35.5 g, 0.15 mol) in absolute EtOH (300 mL) and THF (150
mL). Then sodium borohydride (28.8 g, 0.76 mol) was added
to the solution portionwise at 25 °C. When the reaction became
vigorously, the reaction flask was put into an ice-water bath.
After being stirred at room temperature for 12 h, the reaction
mixture was poured into aqueous citric acid (1 M, 600 mL) at
0 °C and then the solution was extracted with EtOAc (150 mL
× 4). The organic solution was washed with saturated NaCl(aq)
,
(S)-2-Tr ip h en ylm eth yl-4-[(d ip h en ylp h osp h in o)eth yl]-
oxa zolin e 1f. This compound was prepared via the same
method for compound 1b. Beginning with 500 mg (1.17 mmol)
of 8, 191 mg (0.36 mmol, 31%) of the oxazoline 1f was produced
as a colorless oil: Rf 0.71 (EtOAc/hexane, 3:7 v/v); [R]24D -46.6
(c ) 2.9, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 7.25-7.50 (m,
25H), 4.35 (m, 2H), 4.02 (m, 1H), 2.21 (m, 1H), 2.10 (m, 1H),
1.77 (m, 2H); 13C NMR (CDCl3, 75 MHz) δ 169.6, 143.4, 138.4,
138.2, 132.9, 132.6, 132.4, 130.1-126.5, 71.9, 66.8 (d, J ) 13.5
Hz), 61.4, 31.8 (d, J ) 16.5 Hz), 23.7 (d, J ) 11.5 Hz); 31P NMR
(CDCl3, 121 MHz) δ -15.51; HRMS (M+ + 1) m/z calcd for
dried over Na2SO4, filtered, and concentrated to give the diol
11 (23.9 g, 89%) as a white solid: [R]24D -26.4° (c ) 3.04, CH3-
OH); 1H NMR (d6-DMSO, 300 MHz) δ 6.76 (d, J ) 8 Hz, 1H),
3.93 (q, J ) 7 Hz, 2H), 3.58-3.25 (m, 4H), 1.67 (m, 1H), 1.63,
(m, 1H), 1.14, (t, J ) 7 Hz, 3H); 13C NMR (d6-DMSO, 75 MHz)
δ 156.1, 63.5, 59.5, 57.9, 49.9, 34.3, 14.7; HRMS (M+ + 1) m/z
calcd for C7H16NO4 178.10793, found 178.10789.
(S)-4-(2-Hyd r oxyeth yl)-2-oxa zolid in on e 12. Butanediol
11 (19.46 g, 0.11 mol) was dissolved in anhydrous THF (270
mL). Sodium hydride (5.4 g, 0.225 mol) was added to the
solution at 0 °C. The reaction was stirred at 25 °C for 2 h and
refluxed for another 2 h. After being cooled to room temper-
ature, the solution was neutralized with 1 M HCl(aq) and the
solvent was removed under vacuum. The residue was redis-
solved in MeOH (400 mL), dried over Na2SO4, filtered, and
C
36H33NOP 526.22998, found 526.22938.
(S)-2-(9-An th r yl)-4-[(d ip h en ylp h osp h in o)eth yl]oxa zo-
lin e 1g. This compound was prepared via the same method
for compound 11b. Beginning with 500 mg of 8 (1.17 mmol),
27 mg (0.059 mmol, 5%) of the oxazoline 1g was produced as
a light yellow oil: Rf 0.62 (EtOAc/hexane, 3:7 v/v); [R]24D -40.3
evaporated to dryness. The crude 12 (11.4 g, 79%) was obtained
1
as a white solid: [R]24 -11.6° (c ) 2.03, CH3OH); H NMR
D
1
(c ) 1.2, CHCl3); H NMR (CDCl3, 300 MHz) δ 8.52 (s, 1H),
(d6-DMSO, 300 MHz) δ 7.69 (br, 1H), 4.40 (br, 1H), 4.35 (m,
1H), 3.92 (m, 1H), 3.47 (m, 1H), 3.47 (m, 2H), 1.60 (m, 2H);
13C NMR (d6-DMSO, 75 MHz) δ 158.9, 69.5, 57.4, 49.8, 38.0.
(S )-4-[2-(4-Tolu e n e su lfon yloxy)e t h yl]-2-oxa zolid i-
n on e 13. Dry, freshly crystallized p-toluenesulfonyl chloride
(1.6 g, 8.4 mmol) and 4-(dimethylamino)pyridine (20 mg, 0.16
mmol) were added to a solution of alcohol 12 (1.0 g, 7.6 mmol)
and pyridine (15 mL, 0.185 mol) at -10 °C. The resulting
solution was gradually warmed to 25 °C during 12 h. The
reaction mixture was acidified with 2 M HCl (100 mL),
extracted with CH2Cl2 (50 mL × 3), washed with saturated
NaHCO3(aq) and NaCl(aq), dried over Na2SO4, and evaporated.
The crude product was recrystallized twice in EtOAc/hexanes
8.11 (m, 2H), 7.99 (m, 2H), 7.58-7.31 (m, 14H), 4.70 (m, 2H),
4.25 (m, 1H), 2.52 (m, 1H), 2.30 (m, 1H), 1.99 (m, 2H); 13C NMR
(CDCl3, 75 MHz) δ 163.2, 138.6, 138.4, 138.1, 132.9-132.5,
130.9, 130.0, 129.5, 128.7-128.4, 126.7, 125.3, 125.2, 122.7,
72.5, 68.4 (d, J ) 13.5 Hz), 32.7 (d, J ) 17.0 Hz), 24.5 (d, J )
12.0 Hz); 31P NMR (CDCl3, 121 MHz) δ -15.37; HRMS (M+
1) m/z calcd for C31H27NOP 460.18303, found 460.18362.
+
(S)-2-[1-(2-Eth oxy)n a p h th yl]-4-[(d ip h en ylp h osp h in o)-
eth yl]oxa zolin e 1h . This compound was prepared via the
same method for compound 1b. Beginning with 500 mg of 8
(1.17 mmol), 26 mg (0.059 mmol, 5%) of the oxazoline 1h was
produced as a colorless oil: Rf 0.42 (EtOAc/hexane, 3:7 v/v);
[R]24 -36.0 (c ) 0.4, CHCl3); 1H NMR (CDCl3, 300 MHz) δ
to give 13 (0.75 g, 40%) as a light yellow solid: [R]24 -12.5°
D
D
7.87-7.73 (m, 4H), 7.48-7.21 (m, 12H), 4.53 (m, 2H), 4.15 (q,
J ) 7.2 Hz, 2H), 4.10 (m, 1H), 1.32 (t, J ) 7.2 Hz, 3H); 13C
NMR (CDCl3, 75 MHz) δ 161.9, 155.2, 138.5, 138.3, 132.9-
131.6, 128.6-127.3, 123.9, 114.4, 112.9, 72.0, 67.9 (d, J ) 14.0
Hz), 65.3, 32.4 (d, J ) 16.6 Hz), 24.1 (d, J ) 11.0 Hz), 14.9;
31P NMR (CDCl3, 121 MHz) δ -15.11; HRMS (M+ + 1) m/z
calcd for C29H29NO2P 454.19359, found 454.19542.
(c ) 3.82, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 7.76 (dd, J )
7 Hz, J ) 2 Hz, 2H), 7.35 (dd, J ) 7 Hz, J ) 2 Hz, 2H), 6.08
(s, 1H), 4.46 (m, 1H), 4.10 (m, 2H), 3.98 (m, 2H), 2.43 (s, 3H),
1.90 (m, 2H); 13C NMR (CDCl3, 75 MHz) δ 159.6, 145.3, 130.0,
128.9, 127.8, 69.9, 66.9, 49.8, 34.4, 21.6; HRMS (M+ + 1) m/z
calcd for C12H16NO5S 286.07492, found 286.07627.
(S)-4-[2-(Dip h en ylp h osp h in obor a n e)et h yl]-2-oxa zoli-
d in on e 14. n-Butyllithium in hexanes (1.6 M, 17.1 mL, 27.4
mmol) was added to a solution of diphenylphosphine (2.56 g,
13.7 mmol) in THF (120 mL) at 0 °C. The orange-red solution
was stirred at 0 °C for 30 min. The tosylate 13 (3.74 g, 13.1
mmol) dissolved in THF (50 mL) was added to the solution of
phosphide at 0 °C. The resulting solution was stirred at 0 °C
for 1 h. Borane-THF complex (1 M, 14 mL, 14 mmol) was
added to the solution and stirred for another 30 min. The
reaction was quenched with water (10 mL) and then the
solution was neutralized with 1 M HCl(aq), diluted with ether
(S)-N-Eth oxyca r bon yl-Asp a r tic Acid Dim eth yl Ester
10. MeOH (600 mL) was cooled in ice and acetyl chloride (110
mL, 1.54 mol) was added dropwise to generate HCl in situ.
After the addition, L-aspartic acid (64.3 g, 0.48 mol) was added
to the solution at 0 °C and then the solution was slowly
warmed to reflux. The refluxing was continued for 3 h and
the reaction mixture was cooled to room temperature during
overnight. The solvent was removed under reduced pressure
to give the crude dimethyl L-aspartate hydrochloride as viscous
oil. This crude product was further diluted with water (1.6 L)
and cooled in an ice-water bath, and sodium bicarbonate (210
g, 2.5 mol) was added to the solution carefully. Ethyl chloro-
formate was added to the solution dropwise at 0 °C. After the
addition, the solution was stirred at 25 °C for another 4 h and
the product was formed during this period as colorless oil in
the bottom of the flask. The organic layer was separated and
the aqueous solution was further extracted with EtOAc (200
mL × 4). The combined organic solution was washed with
water, saturated NaCl(aq), dried over Na2SO4, filtered ,and
concentrated to give 10 (101.5 g, 0.44mol, 90%) as a colorless
oil: [R]24D +41.6° (c ) 4.65, CHCl3); 1H NMR (CDCl3, 300 MHz)
δ 5.62 (d, J ) 8 Hz, 1H), 4.59 (m, 1H), 4.09 (q, J ) 7 Hz, 2H),
3.73 (s, 3H), 3.66 (s, 3H), 2.99 (dd, J ) 9 Hz, J ) 4 Hz, 1H),
2.82 (dd, J ) 9 Hz, J ) 4 Hz, 1H), 1.22 (t, J ) 7 Hz, 3H); 13C
NMR (CDCl3, 75 MHz) δ 171.2, 171.1, 156.1, 61.2, 52.7, 51.9,
50.2, 36.4, 14.4; HRMS (M+ + 1) m/z calcd for C9H16NO6
234.09776, found 234.09784.
(200 mL), washed with saturated NaHCO3(aq) and NaCl(aq)
,
dried over Na2SO4, and evaporated to yield the oily product
14 (3.9 g, 12.4 mmol, 95%): [R]24 -22.0° (c ) 0.9, CHCl3); 1H
D
NMR (CDCl3, 300 MHz) δ 7.65 (m, 4H), 7.40 (m, 6H), 6.93 (s,
1H), 4.42 (m, 1H), 3.87 (m, 2H), 2.36 (m, 1H), 2,12 (m, 1H),
1.82 (m, 1H), 1.69 (m, 1H); 13C NMR (CDCl3, 75 MHz) δ 160.1,
132.1-131.4, 128.9-128.6, 69.6, 52.8 (d, J ) 15 Hz), 28.7, 21.2
(d, J ) 38 Hz); 31P NMR (CDCl3, 121 MHz) δ 16.3; HRMS (M+
- 1) m/z calcd for C17H20NO2BP 312.13247, found 312.13248.
(S)-2-Am in o-4-d ip h en ylp h osp h in obor a n e-1-bu ta n ol 9.
Oxazolidinone 14 (1.0 g, 3.2 mmol) was dissolved in EtOH (10
mL) and NaOH(aq) (1 N, 10 mL). The solution was refluxed for
2.5 h. The reaction mixture was diluted with ether (100 mL),
washed with saturated NH4Cl(aq) (20 mL), NaCl(aq) (20 mL),
dried over Na2SO4, filtered and evaporated to give 9 as a
colorless oil (0.92 g, 99%): [R]24D 1.6° (c ) 2.8, CHCl3); 1H NMR
(CDCl3, 300 MHz) δ 7.64 (m, 4H), 7.42 (m, 6H), 6.08 (s, 1H),
3.49 (m, 1H), 3.25 (m, 1H), 2.81 (m, 1H), 2.45 (br, 3H) 2.31
(m, 1H), 2.21 (m, 1H), 1.62 (m, 1H), 1.42 (m, 1H); 13C NMR
(S)-2-(Eth oxyca r bon yla m in o)-1,4-bu ta n ed iol 11. Cal-
cium chloride (35 g, 0.63mol) was added to a solution of 10